NANOTECHNOLOGICAL APPROACH TO ENHANCE THE STABILITY AND BIOAVAILABILITY OF THE HERBAL DRUG "MURVA"
Murva (Maerua oblongifolia) contains numerous bioactive compounds that may provide multiple health benefits, including anti-microbial, anti-fungal, anti-pyretic and anti-diabetic. Most of the therapeutic effects of murva have been attributed due to the presence of triterpenoids and alkaloids, in their composition. Although these compounds have been shown promising therapeutic effects under in-vitro conditions, they met with limited efficacy in clinical settings due to various reasons such as poor oral absorption and bioavailability. Different techniques have been proposed to improve the stability and bioavailability of the herbal drugs. Among such strategies, nanoparticulate based drug delivery systems are novel and promising tools. In this study, chitosan nanoparticles containing Murva (CNP1-CNP3) were synthesized by ionic gelation technique, which resulting in particles size smaller than 650nm. The encapsulation efficiency of nanoformulations was over 41.5%. The nanoformulations exhibited slow and sustained in vitro release over 99% of drug from the Murva encapsulated chitosan nanoparticles after 24 hours. The synthesized nanoformulations were found to be a promising system for oral sustained administration of murva and also enhances its stability and bioavailability.
Keywords: Nanoparticles, Murva, chitosan, stability, bioavailability.
2. Alice K, Asha S. Medicinal Plants Horticulture Sciences. 2007; Series 2; New India, New India publication agency.
3. Suffredini, G., & Levy, L. Nanopolymers and nanoconjugates for central nervous system diagnostics and therapies. In B. Kateb & J. D. Heiss (Eds.), The textbook of nanoneuroscience and nanoneurosurgery, 2013; 39–50.
4. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharmaceutical Research, 1996; 13:896–901.
5. Florence A.T. Nanoparticle uptake by the oral route: Fulﬁlling its potential? Drug Discovery Today, 2005; 2:75–81.
6. Torche A.M, Jouan H, Le Corre P, Albina E, Primault R, Jestin A, Le Verge R. Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer’s patch segment. International Journal of Pharmaceutics, 2000; 201:15–27.
7. Kadam R.S, Bourne D.W.A, Kompella U.B. Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: Contribution of reduced clearance. Drug Metabolism and Disposition, 2012; 47:1380–1388
8. Khor E, Lim. L, Implantable applications of chitin and chitosan, Biomaterials, 2003; 24:2339.
9. Prabaharan M, Mano J.F. Chitosan-based particles as controlled drug delivery systems. Drug Deliv; 2005; 12(1):41.
10. Knapczk J, Krowczynski L, Pawlik B, Liber Z, Pharmaceutical dosage forms with chitosan, in G. Skjak-Braek, T. Anthonsen, P. Sandford (Eds.), Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier Applied Science, London, 1984; 1665.
11. Knapczyk J, Chitosan and Chitosan derivatives, Int. J. Pharmaceut. 1993; 93:233.
12. Manivasagan P, Senthilkumar K, Venkatesan J. Biological applications of chitin, chitosan, oligosaccharides and their derivatives. In S. K. Kim (Ed.), Chitin and chitosan derivatives: Advances in drug discovery and developments; 2013, 223–242.
13. Liang J, Yan H, Puligundla P, Gao X, Zhou Y, Wan X. Applications of chitosan nanoparticles to enhance absorption and bioavailability of tea polyphenols: A review. Food Hydrocolloids, 2017; 69:286–292.
14. Mo R, Jin X, Li N, Ju C, Sun M, Zhang C, Ping Q. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials, 2011; 32:4609–4620.
15. Calvo P, Remunan-Lopez C, Vila-Jato J.L. Alonso M.J. Novel Hydrophilic Chitosan–Polyethylene Oxide Nanoparticles as Protein Carriers. Journal of Applied Polymer Science, 1997; 63:125–132.
16. Jessica D, Schiffman L, Caroline L, Schauer. Cross-linking Chitosan Nanofibers. Biomacromolecules, 2007; 8(2):594-601.
17. Amir D, Ebrahim V.F. and Mohammad I. Preparation of Chitosan Nanoparticles Loaded by Dexamethasone Sodium Phosphate. Iranian Journal of Pharmaceutical Sciences Spring, 2008; 4(2):111-114.
18. Nasiri1 M, Azadi A, and Hamidi M. Preparation of chitosan nanoparticles loaded by tramadol using ionic gelation method. Research in Pharmaceutical Sciences, 2012; 7(5).
19. Paresh N, Patel L.J., Patel J.K. Development and testing of novel temoxifen citrate loaded chitosan nanoparticles using ionic gelation method. Der. Pharmacia. Sinica, 2011; 2(4): 17-25.
20. Rabindra K, Nanda S, Patil D Navathar A. Chiotsan Nanoparticles Loaded with Thiocolchicoside. Der. Pharma. Chemica, 2012; 4(4):1619-1625.
21. Wu Y, Yang W, Wang C, Hu J, Fu S. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. International Journal of Pharmaceutics, 2005; 295:235-245.
22. Ravikumara N.R, Nagaraj T.S, Hiremat Shobharani R, Gargi R., Madhusudhan B. Preparation and Evaluation of Nimesulide-loaded Ethyl cellulose and Methylcellulose Nanoparticles and Microparticles for Oral Delivery. Journal of Biomaterial Application, 2009; 24(1):47-64.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).